Oct 27 (Reuters) - STRATEC SE SBSG.DE :
* STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2023
* SIGNIFICANT INTRA-YEAR IMPROVEMENT IN PROFITABILITY IN Q3
OF
2023
* ADJUSTED EBIT MARGIN OF 14.8% IN Q3/2023
* SALES PERFORMANCE STILL ADVERSELY AFFECTED BY EXCESS
MOLECULAR
DIAGNOSTICS CAPACITIES BUILT UP DURING PANDEMIC;
CONSTANT-CURRENCY SALES -9,1% IN 9M/2023
* FINANCIAL GUIDANCE FOR 2023: SALES GUIDANCE SLIGHTLY
ADJUSTED
AND MARGIN TARGET CONFIRMED
Source text for Eikon: ID:nEQ3kRXkWa
Further company coverage: SBSG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))